Posts in National Institutes of Health


Unleashing American Innovation, Oil States and Eroom’s Law

NCATS is working with industry to de-risk promising therapies by helping to take them further down the development pipeline. But the key ingredient remains finding a private …
By Joseph Allen
4 months ago 7

When Big Brother Comes Marching In: Patent Challenges on Entrepreneurial Campuses

Bayh-Dole has recently come under attack, as some are trying to highjack certain provisions to be used as a cost control measure for novel therapeutics as the …

The Plight of the Public Sector Entrepreneur

Being an entrepreneur isn't easy. While it is a tough road for anyone, it's particularly tough if you're in the public sector and threatened by politicians... Rather, …
By Joseph Allen
1 year ago 1

USF files patent suit over sale of Alzheimer’s research mice

On Tuesday, March 21st, a pre-trial hearing will take place in a case involving patent infringement claims targeting the sale of mice having mutated genes which make …
By Steve Brachmann
1 year ago 0

Senate passes 21st Century Cures Act, President Obama expected to quickly sign bill into law

Earlier today, by a vote of 94 to 5, the United States Senate overwhelmingly passed the 21st Century Cures Act. Having passed in the House, the Cures Act now …
By Gene Quinn
2 years ago 6

21st Century Cures Act passed overwhelmingly by House, major health reform bill moves to Senate

The 21st Century Cures Act has broad bipartisan support having been passed in the U.S. House by an overwhelming 344-77 roll call vote. It also has …
By Steve Brachmann
2 years ago 18

Winning the Drug Development Debate

We create two new companies around academic inventions every day of the year. The critical role such companies play in drug development is clear. The successful integration …
By Joseph Allen
2 years ago 0

Toxic algal blooms of today could become the biofuels, fertilizers and antibiotics of tomorrow

At the time of an NIH study in 2011, algae-based biofuel production costs using conventional technologies were anywhere from $300 USD to $2,600 USD per barrel, much higher than the …
By Steve Brachmann
2 years ago 2

The superbugs are here, but where are we?

Superbugs have powerful friends in high places. SCOTUS’s patent eligibility criteria emanating from Mayo/Alice’s mysterious “laws of nature” and credible reports of unremitting turndowns …
By Chris Gallagher
2 years ago 6

NIH Director Collins Stands Up to the March in Mob

The problem with this theory is that the Bayh-Dole Act does not provide agencies the authority to regulate product prices. The law allows universities and contractors to …
By Joseph Allen
2 years ago 0

When Government Tried March In Rights To Control Health Care Costs

As we await the decision from the National Institutes of Health (NIH) on the petition backed by Senator Bernie Sanders and others urging that the march in …
By Joseph Allen
2 years ago 10

Blue Ribbon Panel of Advisors Announced for Biden Cancer Moonshot Initiative

Earlier this week the National Cancer Institute (NCI), which is part of the National Institutes of Health, announced a Blue Ribbon Panel of scientific experts, cancer leaders, …
By Gene Quinn
2 years ago 5

NIH Pressured to Misuse Bayh-Dole to Control Drug Prices

Secretary Burwell and Director Collins are facing formidable pressure to reinterpret the Bayh-Dole Act for the compulsory licensing of costly drugs arising from federally supported research. And …
By Joseph Allen
2 years ago 6

Putting the pieces together on how to cure Alzheimer’s

The most common form of dementia is Alzheimer’s disease, a progressive disorder of the human brain which over time reduces a person’s cognitive abilities to …
By Steve Brachmann
2 years ago 1

Winning the Patent Policy Wars

We're in the business of transforming early stage, publicly funded research into useful products. The odds against success are long as commercialization requires years of hard work, …
By Joseph Allen
2 years ago 2

Our website uses cookies to provide you with a better experience. Read our privacy policy for more information.Accept and Close